Chickenpox traces its origins to Africa, where the varicella-zoster virus (VZV) coevolved with primates and early humans over tens of thousands of years. When anatomically modern humans migrated out of Africa roughly 60,000 years ago, the virus went with them, tucked inside nerve cells. The disease we know today is the product of that long evolutionary partnership, but humans only began to understand it as a distinct illness in the eighteenth century, and the virus itself was not identified until the twentieth.
A Virus That Left Africa Inside Human Nerves
VZV belongs to the alphaherpesvirus subfamily, a group of viruses whose lineage split from other herpesvirus branches somewhere around 180 to 210 million years ago, back when the continents were still fused into Pangaea. Within that ancient family, VZV took a more specific evolutionary path alongside primates. The leading hypothesis, supported by phylogenetic studies, is that the ancestral form of VZV coevolved in simians, apes, and eventually hominins in Africa. When the first populations of modern humans crossed the Red Sea into the Arabian Peninsula and beyond, VZV was already hiding in latent form in their dorsal root ganglia, the clusters of nerve cells along the spine where the virus goes dormant after an initial infection.1PubMed Central. Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and Phylogeography
That timeline received more precision when researchers sequenced 21 VZV genomes and used Bayesian methods to estimate when the virus’s major genetic branches began to split apart. The answer: roughly 110,000 years ago, which lines up with the broader out-of-Africa dispersal of modern humans.2PubMed Central. Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination In other words, as small groups of humans splintered off and migrated to different parts of the globe, they carried slightly different strains of VZV. Over millennia of geographic separation, those strains diverged into the distinct genetic clades that researchers can identify today.
Why VZV Was Built to Travel With Us
Plenty of viruses infect humans, but most burn through a host in days or weeks and then either kill the host, get cleared by the immune system, or run out of new people to infect. VZV solved that problem in an elegant way: after causing the initial chickenpox rash, it retreats into nerve ganglia and goes quiet, sometimes for decades. The virus does not replicate during latency, so it accumulates no new mutations. Its DNA sits in a circular, episome-like form inside nerve cells, with gene activity almost entirely shut down.3PubMed Central. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation
This ability to hide indefinitely made VZV the perfect traveling companion for small, scattered bands of early humans. A virus that depends on rapid person-to-person spread would have died out in groups of a few dozen individuals. But VZV could infect a child, go dormant, and then reactivate decades later as shingles, producing fresh virus that could infect a new generation. Research on the vaccine strain of VZV estimated that the virus actively replicates for only about 13 days before establishing latency.4PubMed Central. Rates of Vaccine Evolution Show Strong Effects of Latency: Implications for Varicella Zoster Virus Epidemiology After that short burst, the virus essentially freezes in place inside your neurons. That brief window of activity, followed by indefinite dormancy with the option to wake up later, is what allowed VZV to persist through millennia of low human population density.
Centuries of Confusion With Smallpox
Although shingles (herpes zoster) has been described in medical texts since antiquity, chickenpox itself was a late arrival in the medical literature, partly because physicians kept confusing it with smallpox. Both diseases produce skin eruptions, and before modern virology, there was no way to distinguish one virus from another. The two illnesses were lumped together for centuries.5PubMed Central. Zeroing in on zoster: A tale of many disorders produced by one virus
The first clear separation came in 1767, when the English physician William Heberden published a detailed clinical description of chickenpox that distinguished it from smallpox.6PubMed Central. Poxes great and small: The stories behind their names Heberden pointed out differences in the size, shape, and progression of the lesions that made the two conditions recognizably distinct to a trained eye. Still, well into the 1800s, many practitioners continued to treat chickenpox and smallpox as related disorders. It took until the twentieth century for researchers to demonstrate that VZV causes chickenpox upon first infection and then, if it reactivates from its latent state, causes shingles.5PubMed Central. Zeroing in on zoster: A tale of many disorders produced by one virus That one virus could produce two seemingly different diseases in the same person, separated by decades, was a genuinely surprising discovery at the time.
Smallpox itself has an interesting parallel timeline. Ancient DNA work on Viking-era remains from northern Europe (600 to 1050 CE) found variola virus sequences from a now-extinct lineage distinct from the strains that caused modern smallpox, with the different lineages sharing a common ancestor around 1,700 years ago.7PubMed Central. An Adagio for Viruses, Played Out on Ancient DNA No equivalent ancient DNA discovery has been made for VZV, but the point stands that the “pox” diseases familiar to medieval and early modern physicians had deep, tangled histories that were invisible without molecular tools.
Where the Name “Chickenpox” Comes From
The word “chickenpox” has no single accepted origin, which makes it a surprisingly fun etymological puzzle. Samuel Johnson, the great English lexicographer, suggested in the eighteenth century that the name reflected the disease’s mildness: it was a “chicken” version of smallpox, an imitation that looked like the real thing but was far less dangerous. Other scholars have proposed that “chicken” is a corruption of “chick-pea,” referring to the size of the blisters. The term “chick-pease” was used in seventeenth-century English to describe a skin eruption, mirroring the Italian word “ciceris,” which could mean both chick-pea and a skin blemish. A third theory traces “chicken” back to “chicking,” a garbled form of “itching,” while a fourth connects it to the Old English word “chiche,” meaning miserly or trivial, again emphasizing that this was the small, paltry version of the pox.8PubMed Central. Chickenpox None of these explanations has won a decisive majority among historians of medicine, which is why you will still find all four offered in different reference sources.
VZV’s Closest Living Relative
If VZV coevolved with primates in Africa, you would expect to find closely related viruses in other primates, and that is exactly what researchers have found. Simian varicella virus (SVV), originally isolated from monkeys that developed a chickenpox-like rash, is the closest known relative of VZV. The two viruses have genomes that are similar in size, arranged in the same order, and share about 96 percent of their functional genes.9PLOS Pathogens. The architecture of the simian varicella virus transcriptome Infecting monkeys with SVV reproduces many of the same features seen in human chickenpox and shingles, including the pattern of latency and reactivation, which makes SVV-infected primates the primary animal model for studying VZV biology.
The existence of SVV is a living fossil of sorts. It gives researchers a window into what the common ancestor of these viruses may have looked like before the human and monkey lineages split. VZV and SVV diverged along with their respective hosts, which reinforces the coevolution narrative: the virus did not jump from one species to another in recent history. It has been riding along with primates for millions of years, specializing in each host lineage as that host evolved.
How VZV Compares to Its Herpesvirus Cousins
VZV and herpes simplex virus type 1 (HSV-1, the virus behind cold sores) are both human alphaherpesviruses that hide in nerve ganglia, but their evolutionary histories look quite different. HSV-1 is at least four times more genetically diverse than VZV, which likely reflects a much longer period of independent evolution in human populations.10PLOS ONE. A Genome-Wide Comparative Evolutionary Analysis of Herpes Simplex Virus Type 1 and Varicella Zoster Virus HSV-1 genomes recombine with each other so frequently that assigning any one strain to a neat phylogenetic clade is essentially meaningless. VZV, by contrast, can be sorted into a handful of clearly defined clades that map to geographic regions, making it a much tidier subject for tracing human migration patterns.
That said, VZV is not as genetically static as it once appeared. Genomic analyses have identified frequent recombination events within VZV clades, and some evidence suggests that vaccine-derived strains have already been involved in recombination, either inside patients or during laboratory passage of the virus.11PubMed Central. Recombination of Globally Circulating Varicella-Zoster Virus More recent work on VZV strains circulating in Beijing found dozens of putative recombination events and evidence of adaptive mutations that may help certain strains thrive in specific populations.12Virus Evolution. Decoding VZV’s evolutionary arsenal: how Beijing strains use recombination and adaptive mutations to thrive So while VZV evolves slowly compared to many viruses, it is not standing still.
Why Chickenpox Looks Different in the Tropics
If you grew up in a temperate country, you probably think of chickenpox as a childhood disease that sweeps through elementary schools in late winter or early spring. In tropical countries, the pattern is different. VZV infections still occur, but children are less likely to be infected at a young age, which pushes the average age of first infection into adolescence or young adulthood. That shift matters because chickenpox tends to be more severe in older patients, which means tropical regions see higher rates of complications in high school students, university students, and young workers.13PubMed Central. Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka
The reasons behind this geographic difference are not fully settled. Climate probably plays a role: VZV is a fragile virus that does not survive long outside the body, and it may spread less efficiently in hot, humid air than in the cold, dry indoor air of temperate winters when people cluster together. Socioeconomic factors, population density, and cultural practices around child-rearing also seem to influence how early children encounter the virus. What is clear is that “chickenpox is a mild childhood disease” is a statement that applies most neatly to temperate, high-income settings. In tropical countries, the same virus causes a meaningfully different public health burden.
Human Genetics and Who Gets Hit Hardest
The virus may have traveled the world with us, but not everyone responds to it in quite the same way. Research into host susceptibility genes has found that certain genetic variants near the HLA region of chromosome 6, a stretch of DNA critical to immune function, are associated with increased chickenpox susceptibility. In particular, increased expression of genes called HLA-S, HCG4P5, and ABHD16A appears to be linked to higher vulnerability. The allele frequencies of the relevant variants are higher in European, American, and African populations compared to Asian populations, which could partly explain observed differences in chickenpox burden across continents.14PubMed Central. Investigation of susceptibility genes for chickenpox disease across multiple continents
This is still early-stage research, and no one is suggesting that genetics alone determines who gets chickenpox. Virtually everyone who encounters VZV without prior immunity will become infected. The genetic differences are more about severity and progression than about whether infection happens at all. But the finding does reinforce the broader point that VZV and human populations have been shaping each other for a very long time, and the traces of that coevolution are visible in our DNA.
The Vaccine and the Boy Named Oka
For most of human history, chickenpox was simply a fact of life. That changed in the 1970s, when Michiaki Takahashi, a Japanese virologist, developed the world’s first live attenuated varicella vaccine. Takahashi isolated VZV from the fluid in the blisters of a child with typical chickenpox. The virus strain was named “Oka” after the boy’s family name, and it became the basis of every varicella vaccine used worldwide to this day.15PubMed. Development of varicella vaccine in Japan and future prospects
Takahashi’s motivation was partly personal. His son had come down with a severe case of chickenpox, and the experience convinced him that a vaccine was worth pursuing, even though many colleagues at the time considered chickenpox too mild to warrant one. The Oka strain was weakened through repeated passage in cell cultures until it could trigger an immune response without causing full-blown disease. Japan began using the vaccine in the 1980s, and the United States added it to the routine childhood schedule in 1995.
The vaccine’s success created a new layer of evolutionary questions. Since the Oka strain is a live virus, it can establish latency in nerve ganglia just like wild-type VZV, and it can occasionally reactivate to cause a mild form of shingles. Genomic studies have found evidence that vaccine-derived strains can recombine with each other during replication, raising the question of whether recombination between vaccine and wild-type strains could eventually produce new viral variants.11PubMed Central. Recombination of Globally Circulating Varicella-Zoster Virus So far, no vaccine-wild type recombinant has been detected between different clades, but it remains something virologists are watching.
What Ancient DNA Has Not Yet Told Us
Paleogenomics has become a powerful tool for tracing the histories of human pathogens. Researchers have recovered ancient DNA from smallpox, plague, hepatitis B, and other infections in archaeological remains. For VZV, though, the ancient DNA record is essentially blank. This is not entirely surprising. VZV is a latent virus that lives inside neurons, not in the blood or respiratory tract, and it circulates at low levels in the body even during active infection. The tissues most likely to harbor VZV DNA, such as spinal ganglia, are not the tissues that survive best in archaeological contexts. Bones and teeth, which preserve well, are far less likely to contain VZV.
Without ancient DNA, the evolutionary history of VZV depends almost entirely on comparing the genomes of modern strains and working backward using molecular clock estimates. Those estimates have converged on the 60,000-to-110,000-year timescale discussed earlier, but this approach has inherent uncertainties. Molecular clocks depend on assumptions about how fast mutations accumulate, and VZV’s long periods of dormancy complicate the picture because mutations only accumulate during active replication.4PubMed Central. Rates of Vaccine Evolution Show Strong Effects of Latency: Implications for Varicella Zoster Virus Epidemiology If ancient VZV DNA is ever recovered, it could anchor the molecular clock in a way that significantly sharpens our understanding of when and where the virus diversified. Until then, the out-of-Africa model remains the best-supported hypothesis, but it is built on inference rather than direct observation of the ancient virus.